Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CERTOLIZUMAB PEGOL Cause Injection site reaction? 1,253 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 1,253 reports of Injection site reaction have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 1.3% of all adverse event reports for CERTOLIZUMAB PEGOL.

1,253
Reports of Injection site reaction with CERTOLIZUMAB PEGOL
1.3%
of all CERTOLIZUMAB PEGOL reports
321
Deaths
627
Hospitalizations

How Dangerous Is Injection site reaction From CERTOLIZUMAB PEGOL?

Of the 1,253 reports, 321 (25.6%) resulted in death, 627 (50.0%) required hospitalization, and 322 (25.7%) were considered life-threatening.

Is Injection site reaction Listed in the Official Label?

Yes, Injection site reaction is listed as a known adverse reaction in the official FDA drug label for CERTOLIZUMAB PEGOL.

What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?

Drug ineffective (23,838) Rheumatoid arthritis (17,782) Pain (13,929) Fatigue (11,438) Off label use (10,281) Rash (9,663) Alopecia (9,111) Maternal exposure during pregnancy (9,013) Arthralgia (8,993) Abdominal discomfort (8,615)

What Other Drugs Cause Injection site reaction?

ETANERCEPT (9,962) ADALIMUMAB (4,375) NALTREXONE (4,360) DUPILUMAB (4,129) GLATIRAMER (3,317) IXEKIZUMAB (1,701) METHOTREXATE (1,663) TIRZEPATIDE (1,389) TOCILIZUMAB (1,343) ABATACEPT (1,190)

Which CERTOLIZUMAB PEGOL Alternatives Have Lower Injection site reaction Risk?

CERTOLIZUMAB PEGOL vs CERTOPARIN CERTOLIZUMAB PEGOL vs CETIRIZINE CERTOLIZUMAB PEGOL vs CETIRIZINE\PSEUDOEPHEDRINE CERTOLIZUMAB PEGOL vs CETRIMIDE CERTOLIZUMAB PEGOL vs CETRORELIX

Related Pages

CERTOLIZUMAB PEGOL Full Profile All Injection site reaction Reports All Drugs Causing Injection site reaction CERTOLIZUMAB PEGOL Demographics